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Deficiencies in the organisation and delivery of care in all health systems that have been studied 
are now well recognised and recorded in the scientific literature. Rectifying these deficiencies 
has proved challenging. In this paper the authors argue that one reason that patients so often 
receive inadequate care is because efforts to improve services have been insufficiently informed 
by science. They propose that the science of improvement needs to be developed, promoted 
and embedded within health services through a partnership between clinicians, managers, 
academics and those who use health services. Using three examples of published improvement 
studies that have been subjected to rigorous evaluation, they describe the characteristics of this 
science and propose a strategic approach to optimise the impact of the science of improvement 




The remarkable achievements of modern health care make the deficiencies associated with the 
delivery of care all the more striking. Patients are routinely exposed to wide and inexplicable 
variations in quality of care, such as an eight-fold variation across England in the number of 
patients who receive angioplasty for severe myocardial infarction.
1
 Healthcare is now a major 
source of harm, with about one in ten patients admitted to hospital suffering an adverse event, 
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with there is little evidence of improvement over time.
3
 On average, about half of the clinical 
processes that would generally be accepted as good clinical practice are actually implemented. 
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Problems of variations in care, preventable patient harm and poor quality are common to all 
health systems, irrespective of how they are organised or financed. These problems have proved 
remarkably difficult to address, despite good intentions, ambitious programmes of improvement 
and the investment of significant resources. 
5
 In this article, we propose that one reason that 
patients are often failed by healthcare, in major and minor ways, is that improvement efforts have 
been insufficiently informed by science. We outline the characteristics of a science of 
improvement, and identify what needs to happen for healthcare to benefit from the application of 
such a science. 
Different stances have been typically been adopted by those attempting to understand and 
address the challenge of improvement. Some, particularly at policy level, see the problem as 
primarily a managerial one, and frame the challenge pragmatically as one of „delivery‟, 
„governance‟ and having the right financial incentives in place.
6
 Others adopt a more technical 
stance, focused on how scientific evidence should inform practice, and frame the challenge as 
one of „implementation‟. 
7
  Yet others frame the challenge as one of “quality improvement”, 
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borrowing from approaches used in manufacturing and other industries, and using specific 
techniques to try to engineer change. 
8
 Attention to this third position has gathered increasing 
momentum in recent years, so that a quality improvement “movement” is now said to exist. 
This movement has made a valuable contribution, not least in challenging overly technocratic, 
managerialist, or regulatory-focused approaches to change. However, the urge to action can 
easily overwhelm the need for evidence, to the extent that much quality improvement work is 
unscientific in its orientation: it is neither based on high quality evidence nor subject to rigorous 
evaluation to determine its effectiveness, costs, and risks. The irony is that such work risks 
producing exactly the opposite of improvement: resources can be wasted, energy and 
enthusiasm dissipated, the side-effects of intervention ignored, and in the end little demonstrable 
positive change may be seen. The body of systematic, accessible and rigorous knowledge about 
best how to improve remains meagre. Adopting a more scientific approach to improvement has 
the potential to enhance the ability of health systems and those who work in them to provide high 
quality care and to use resources more efficiently and effectively.  
Defining the science of improvement 
As is often the case in what Kuhn
9
 refers to as a „pre-paradigm‟ phase of the emergence of a 
new discipline, no single agreed definition of the science of improvement exists. Attempts to 
produce one can provoke fierce debate, and to date the term has escaped consensus. 
10
 We 
suggest that healthcare improvement science has four distinguishing characteristics: (i) a body of 
content knowledge focused on improving the delivery of care to patients; (ii) a set of methods for 
investigating research questions relating to improvement of healthcare; (iii) a set of theories 
operating on different levels, including the “small theories” of individual programmes and the “big 
theories” of social phenomena  (iv) a set of values that underpin the ethical commitments of the 
science. 
The science of improvement draws on a rich heritage of contributing disciplines. As a 
consequence, it utilises a range of different theories, methodologies and research methods. 
Using three examples, we explore the value of treating improvement as a science, and use these 
examples to identify some of the characteristics of good improvement science. 
Example 1: Reducing central line infections in Intensive Care Units  
The first example (Box A) aimed to reduce central line infections in intensive care units (ICUs) in 
the United States. Such infections represent a significant clinical problem with often fatal 
consequences, and are very costly to treat. A cohort study conducted in over 100 ICUs in the 
state of Michigan in 2004/5 showed that a multi-component programme comprising  evidence-
based technical interventions, adaptive interventions targeted on culture and systems, and  a 
centralised data collection and feedback system resulted in a large reduction in rates of catheter-
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related bloodstream infections. A later study found that these improvements were sustained in 
participating ICUs compared with controls.  Follow up work undertaken by members of original 
study, in partnership with social scientists, explored the mechanisms through which the 
programme worked, and generated a theory of change that could inform and be tested in 
subsequent iterations of the programme.  
[Insert Box 1] 
Example 2: Increasing the identification and referral of victims of domestic violence 
The second example (Box B) aimed to increase, in UK primary care, rates of identification and 
referral to specialist advocacy services of women subjected to domestic violence. Again, the 
study addressed a common and important challenge for health systems, and one that is often 
inadequately managed despite the major health and social implications of unidentified and 
unmanaged abuse. A cluster randomised controlled trial was undertaken in 51 primary care 
clinics in 2 large cities in the UK in 2007/8, utilising a range of evidence-based interventions. It 
showed an increase in recorded disclosures of domestic violence and in referral to specialist 
services in the intervention group.  
[Insert Box 2] 
Example 3: Reducing door to balloon time for patients with myocardial infarction 
The third example (Box C) aimed to reduce “door to balloon” time for patients with ST segment 
elevation myocardial infarction (STEMI) in hospitals in the United States. There was good 
evidence at the outset that prompt reperfusion treatment reduces the mortality and morbidity of 
STEMI patients (“time is muscle”). However, few hospitals met the standard of 90 minutes or 
less from entering the emergency department (door) to receiving treatment in the cardiac 
catheterisation laboratory (balloon). A mixed method approach involving in-depth interviews, 
surveys and modelling techniques identified and quantified the most effective strategies and 
helped improve the proportion of patients getting to “balloon” on time from 50% to 75%.  
[Insert Box 3] 
More than anything, perhaps, these studies underline the extent to which improvement 
interventions and their causal mechanisms are deeply and inescapably complex. As Lipsey 
describes: “They involve multidimensional interactions that are often extended over time, 
complex multistep causal processes in which different individuals may react differently, and 
uncertain and potentially wide-ranging outcomes, not all necessarily desirable”.
11
 Such complex 
interventions need a sophisticated science to match.  
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The three examples demonstrate some of the characteristics of that science. They all contribute 
to the development of content knowledge: it is now much clearer “what works” in reducing 
infection in central lines, improving the support of women at risk of domestic abuse, and 
enhancing the chances of a successful outcome for patients with a severe myocardial infarction. 
They also make use of a set of evaluative methods that are well established and enjoy high 
credibility among practising clinicians and decision-makers, but are adapted for the specifics of 
the area in which they are applied. In their own way, each represents a methodological 
innovation. These three studies also make a contribution to the theoretical development of the 
field, by helping to reveal the mechanisms through which improvement interventions work. 




Characteristics of a science of improvement 
Analysis of these examples highlights four characteristics of a science of improvement in 
healthcare. None is unique to this science, but together they help to explain what it is about: 
Improvement science attempts to generate practical learning that can make a timely 
difference to patient care. Each of the examples we discuss has resulted in practical learning 
to help health services to improve patient outcomes.  Improvement science focuses on 
identifying and helping to solve problems concerned with quality or safety of care. It is therefore 
characterised by its substantive field of interest, by its applied nature, and by its commitment to 
learning that can be applied in practice. In this, it recognises and integrates multiple 
contributions, much as engineering science uses scientific knowledge and theories to address 
real-life problems. This helps to address the challenge that those making decisions about 
patients do not always see traditional health services research as “useful”. 
 
 Improvement science aims to produce generalisable or transferable knowledge, and it 
utilises robust, well established research methods applied in highly pragmatic ways. For 
each of the programmes we describe, the improvement activities were conducted in a way that 
enabled local improvement but produced knowledge with external validity, which was then 
published as an enduring historical record in well-respected journals that ensured both critical 
peer review and wide dissemination. Developing local knowledge based on a strong sense of 
ownership and a willingness to adapt improvement activities is clearly important. But wherever 
possible, there is an obligation, based on both moral and practical imperatives, to learn 
systematically, and to produce generalisable or transferable knowledge about how to 
improve.
12
However, many quality improvement projects at present rely on contemporaneous, 
non-standardised, non-verified data to make judgements about their effectiveness. In so doing, 
they may be prone to bias, and they frequently demonstrate effect sizes that prove hard to 
replicate in more objective evaluations. In contrast, a science of improvement is characterised by 
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its commitment to rigorous evaluative methods and high quality data collection and 
interpretation. The choice of methods in improvement science is, however, often guided by 
pragmatism and in particular by the formidable realities of intervening and collecting data in 
messy, highly heterogeneous real-life clinical situations outside of the clean world of the 
laboratory or the randomised controlled trial of a medicinal product. Thus, the decision to use a 
cohort design in the central line infection study rather than an RCT reflected a recognition that 
randomisation would not have been acceptable to those involved, who primarily saw themselves 
as participants in an improvement rather than a research project. It might also have been useful 
to have known which elements of the complex intervention were most effective, but this would 
have greatly increased the burden of data collection for the teams, and posed a risk to subject 
recruitment and retention that the authors did not consider worth taking. The door-to-balloon 
studies showed how combining multiple data sources – qualitative and quantitative – can provide 
clear, practical guidance on where organisations need to target their efforts.  
Improvement science requires a genuine partnership between academics and front line 
practitioners. Researchers bring scepticism, scientific rigour and methodological technical 
expertise. Practitioners bring content knowledge and a deep understanding of working contexts. 
Both are needed for improvement science, as our three examples illustrate. For the central 
venous catheter work, the study was initiated by a doctor and a nurse, working with health 
service researchers, statisticians, and others. Additional insights into the mechanisms of action 
were provided subsequently through a partnership with social scientists. The domestic violence 
study involved clinicians, community social workers, statisticians and economists. The door-to-
balloon study involved clinicians, public health specialists, epidemiologists, social scientists and 
modellers. In all cases, the academic and the service partners were both actively involved in 
designing, undertaking and interpreting the work, creating a synergy across boundaries that 
moves the learning beyond that gained from traditional research or quality improvement work. 
Partnership between researchers and practitioners, or between different disciplines, is not a 
passive or rigidly compartmentalised one, but rather one of mutual support, respect and healthy 
challenge. Further, they are partnerships between equals, not one where one discipline or group 
is seen as subordinate or the servant of the other. 
Improvement science draws on, and aims to contribute to, clear and explicit theories of 
how change happens. A major activity of improvement science centres on the design, 
deployment, and evaluation of complex, multi-faceted interventions. Improvement efforts should 
be based on good theory, but too often interventions are designed without the benefit of previous 
learning or explicating the assumptions about how and why change is likely to occur. There is a 
rapidly developing evidence base to guide effective improvement practice, describing what 
works, to what extent and the unintended consequences. Too often improvement projects ignore 
this evidence base and are less effective as a consequence.  As a result, many quality 
improvement interventions remain black boxes that are difficult to reproduce in new contexts. It is 
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important that the underlying theories, or hypothesised mechanisms of change, are surfaced for 
each intervention or programme. In each of the three examples, the interventions were chosen 
on the basis of published evidence and each of the studies built on this evidence in an 
incremental way, but also allowed room for innovation. For the door-to-balloon, study the authors 
hypothesised that clear managerial strategies and specific practical guidance would change the 
behaviour of those planning care for acute myocardial infarction. The authors of the domestic 
violence study placed a strong emphasis on advocacy-led education and training and feedback 
as a vehicle for change. The central line infection team hypothesised that multiple interventions 
at all levels of the system were required and that a delicate balance between facilitative and 
coercive approaches was needed. The central line study also demonstrates the benefits of a 
flexible and evolutionary approach to theory development.  
 
Discussion  
We have attempted to describe the science of improvement in healthcare and make the case for 
its relevance to those responsible for improving the quality of care provided for patients. Science-
guided improvement has the potential to more effectively address the gap between what is done 
and what is known should be done, to identify what should be done where that is unknown, and 
to accelerate progress by prioritising systematic learning as a feature of health services. 
13
 Front-
line practitioners deserve high quality evidence on which to base their efforts to serve patients; 
good intentions are not enough. By integrating science with clinical priorities, by bringing 
together those who do the work of caring for patients with those who study that work, and by 
committing all those involved to the same values, the science of improvement is rich in its 
potential to benefit patients. 
A strategic approach is required to optimise the impact of improvement science. First, the policy, 
service and academic communities need to learn about improvement science, the synergistic 
relationship between this science and the more familiar biomedical and clinical sciences, and 
how the science can be used to make a difference to patient care.   This will likely require 
academia to break out of rigid and unhelpful departmental silos and work in interprofessional 
research teams, and for incentives to be changed to encourage this. It is clear that no single 
academic discipline can address the needs of improvement science: the list of those who 
contribute includes (but is not limited to) operations research and industrial engineering, clinical 
science, health and behavioural economics, management studies, sociology and anthropology, 
psychology, statistics and mathematics, epidemiology, policy analysis, philosophy and ethics and 
human factors and systems engineering. A growing number of institutions around the world are 
demonstrating the benefits of such wider collaboration. 
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Second, there is a need to build capacity and capability in the field at all levels from improvement 
science leaders, such as the recently launched Health Foundation Improvement Science 
Fellowship scheme in the UK and similar schemes which are being planned in Sweden and the 
Netherlands. Third, the counter-cultural nature of improvement science for traditional service and 
academic sectors needs to be recognised and space provided to develop new ways of thinking 
and acting. This will require a redefinition of some of the success criteria in both the academic 
sector (where the desire to make a difference is rarely rewarded) and the service sector (where 
the development and application of scientific evidence is not always highly regarded). Some 
leading institutions are starting to recognise the need for change. For example, Johns Hopkins 
University in the USA has recently developed promotion criteria for faculty doing improvement 
work, based on measurable improvements for patients and the development of transferable 
learning. 
Fourth, the creation of an international network or body to support the emerging science and 
assist improvement scientists in sharing learning would help to ensure that the development of 
the science is an outward looking endeavour. Finally, funding is required to establish and support 
centres for improvement science, bringing together diverse academic and clinical disciplines 
within discrete health economies and to promote high quality improvement projects and capacity 
building activities. 
If this strategy is successful, within the next decade the science of improvement will be 
embraced as a mainstream body of knowledge and set of activities that will be an essential 
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Pronovost et al NEJM (2006) 
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 A cohort study conducted in 103 ICUs in the state of Michigan, 
this programme aimed to reduce catheter-related blood stream infections using a complex 
intervention with some evidence-based and some innovative components. The median rate of 
infections per 1000 catheter days decreased from 2.7 infections at baseline to 0 at 3 months 
after the implementation of the intervention and the mean rate per 1000 catheter days decreased 
from 7.7 at baseline to 1.4 at 16 to 18 months of follow-up (a 66% reduction).  
Lipitz-Snyderman et al BMJ (2010)
15
 Using a retrospective, observational study design, this 
study compared mortality in patients aged over 65 admitted to ICUs 95 Michigan hospitals with a 
control group of 364 hospitals in 11 surrounding states. It found significantly decreased mortality 
in Michigan hospitals compared with controls: the chance of dying in an ICU reduced by 24% in 
Michigan compared with a reduction of 16% in other mid-western hospitals. 
Dixon-Woods et al Milbank Quarterly (2011)
16
 This article attempted to explain the success of 
the Michigan programme using a combination of social science theory and the accounts of the 
programme designers. It suggested that important factors included the redefinition of central line 
infections as a social problem requiring concerted and collective action rather than a simple 
technical problem; the role of peer pressure and importance of social networks in facilitating 
change; the judicious use of “hard edges” or managerial approaches to changing behaviour, 
alongside more facilitative profession approaches; and the creation of a clinical community 








Feder et al, The Lancet, 2011 
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 A cluster-randomised trial conducted in 48 primary care 
practices in the UK that aimed to improve the identification and referral of women experiencing 
domestic violence. The trial tested a complex, multifaceted intervention  including 
multidisciplinary  practice-based training sessions with significant lay input, prompts in the 
medical record system, continuous a pathway that could be offered to women to access 
resources, cards and posters in surgeries, continuous reinforcement and informal contact, and 
feedback on referrals.  1 year after the intervention, a dramatic increase in rates of referral to 
advocacy services in the intervention practices was observed (adjusted intervention rate ratio of 
22.1, 95% confidence interval 11.5-42.4), together with a smaller increase in recorded 









McNamara et al, Journal of the American College of Cardiology 2006 
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Using a cohort study design of 29,222 patients, this study established that longer door-to-balloon 
time was associated with increased in-hospital mortality and is relevant regardless of time from 
symptom onset and baseline risk of mortality. 
Bradley et al, NEJM 2006 
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This study sought to identify and quantify operational and clinical processes to reduce door-to-
balloon times. Using a survey methodology and modelling techniques it found six strategies were 
positively associated with faster door to balloon times: emergency department doctors activating 
the catheterization laboratory; having a single call to a central page to mobilise the laboratory; 
activating the laboratory while the patient was en route to hospital; expecting staff to arrive in the 
laboratory within 20 minutes of being paged;  having a consultant (attending) physician 
permanently on site; and real-time data feedback to staff in the emergency department and the 
catheter lab. The temporal impact of each of these strategies were calculated and using four of 
them were found to result in a door to balloon time of 79 minutes in comparison with 110 minutes 
when none of them were used. 
Bradley et al, Circulation, 2006 
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A qualitative study using depth interviews with 122 hospital staff at 11 hospitals that had median 
door-to-balloon times of 90 minutes or less, this work showed that setting explicit goals, having 
visible support of senior management and uncompromising clinical leaders, standardised clinical 
protocols but flexibility in implementation, collaborative interdisciplinary teams, data feedback to 
monitor progress and identify successes or problems, and positive organizational culture were all 
implicated in shorter transits between door and catheterization laboratory.  
Bradley et al, Journal of American Journal of Cardiology, 2009 
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This study showed, using a longitudinal study of 831 hospitals, that participation in a national 
programme (the D2B Alliance) that recommended use of the strategies identified by the earlier 
studies was associated with marked improvement in practice and performance in the delivery of 
PPCI for patients with STEMI. By March 2008, more than 75% of patients had D2B times of 90 
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